Developing non-opioid therapeutics to alleviate pain among persons with opioid use disorder: a review of the human evidence

References

• Abdelemam, R. M., Fares, K. M., & Kamal, S. M. (2022). Effect of combined epidural morphine and midazolam on postoperative Pain in patients undergoing major abdominal cancer surgery. The Clinical Journal of Pain, 38(11), 693–699. doi: 10.1097/AJP.0000000000001071.
   PubMed Web of Science ®Google Scholar
• Abrams, D. I., Couey, P., Shade, S. B., Kelly, M. E., & Benowitz, N. L. (2011). Cannabinoid-opioid interaction in chronic pain. Clinical Pharmacology and Therapeutics, 90(6), 844–851. doi: 10.1038/clpt.2011.188.
   PubMed Web of Science ®Google Scholar
• Afzalimoghaddam, M., Edalatifard, M., Nejati, A., Momeni, M., Isavi, N., & Karimialavijeh, E. (2016). Midazolam plus haloperidol as adjuvant analgesics to morphine in opium dependent patients: A randomized clinical trial. Current Drug Abuse Reviews, 9(2), 142–147. doi: 10.2174/1874473710666170106122455.
   PubMedGoogle Scholar
• Ahmed, S., Bachu, R., Kotapati, P., Adnan, M., Ahmed, R., Farooq, U., Saeed, H., Khan, A. M., Zubair, A., Qamar, I., & Begum, G. (2019). Use of Gabapentin in the treatment of substance use and psychiatric disorders: A systematic review. Frontiers in Psychiatry, 10, 228. doi: 10.3389/fpsyt.2019.00228.
   PubMed Web of Science ®Google Scholar
• Alper, K. R., Lotsof, H. S., Frenken, G. M., Luciano, D. J., & Bastiaans, J. (1999). Treatment of acute opioid withdrawal with ibogaine. American Journal on Addictions. 8(3), 234–242.
   PubMed Web of Science ®Google Scholar
• AlSharari, S. D., Carroll, F. I., McIntosh, J. M., & Damaj, M. I. (2012). The antinociceptive effects of nicotinic partial agonists varenicline and sazetidine-A in murine acute and tonic pain models. The Journal of Pharmacology and Experimental Therapeutics, 342(3), 742–749. doi: 10.1124/jpet.112.194506.
   PubMed Web of Science ®Google Scholar
• Andersson, M., Persson, M., & Kjellgren, A. (2017). Psychoactive substances as a last resort-a qualitative study of self-treatment of migraine and cluster headaches. Harm Reduction Journal, 14(1), 60. doi: 10.1186/s12954-017-0186-6.
   PubMedGoogle Scholar
• Argento, E., Socias, M. E., Hayashi, K., Choi, J., Mackay, L., Christie, D., Milloy, M.-J., & DeBeck, K. (2022). Psychedelic use is associated with reduced daily opioid use among people who use illicit drugs in a Canadian setting. The International Journal on Drug Policy, 100, 103518. doi: 10.1016/j.drugpo.2021.103518.
   PubMed Web of Science ®Google Scholar
• Arout, C. A., Waters, A. J., MacLean, R. R., Compton, P., & Sofuoglu, M. (2019). Minocycline does not affect experimental pain or addiction-related outcomes in opioid maintained patients. Psychopharmacology, 236(10), 2857–2866. doi: 10.1007/s00213-018-5146-7.
   PubMed Web of Science ®Google Scholar
• Babalonis, S., Lofwall, M. R., Sloan, P. A., Nuzzo, P. A., Fanucchi, L. C., & Walsh, S. L. (2019). Cannabinoid modulation of opioid analgesia and subjective drug effects in healthy humans. Psychopharmacology, 236(11), 3341–3352. doi: 10.1007/s00213-019-05293-1.
   PubMed Web of Science ®Google Scholar
• Ballreich, J., Mansour, O., Hu, E., Chingcuanco, F., Pollack, H. A., Dowdy, D. W., & Alexander, G. C. (2020). Modeling mitigation strategies to reduce opioid-related morbidity and mortality in the US. JAMA Network Open, 3(11), e2023677. doi: 10.1001/jamanetworkopen.2020.23677.
   PubMed Web of Science ®Google Scholar
• Barrett, F. S., Doss, M. K., Sepeda, N. D., Pekar, J. J., & Griffiths, R. R. (2020). Emotions and brain function are altered up to one month after a single high dose of psilocybin. Scientific Reports, 10(1), 2214. doi: 10.1038/s41598-020-59282-y.
   PubMed Web of Science ®Google Scholar
• Bernstein, Z. P., Yucht, S., Battista, E., Lema, M., & Spaulding, M. B. (1998). Proglumide as a morphine adjunct in cancer pain management. Journal of Pain and Symptom Management, 15(5), 314–320. doi: 10.1016/s0885-3924(98)00003-7.
   PubMed Web of Science ®Google Scholar
• Bleakman, D., Alt, A., & Nisenbaum, E. S. (2006). Glutamate receptors and pain. Seminars in Cell & Developmental Biology, 17(5), 592–604. doi: 10.1016/j.semcdb.2006.10.008.
   PubMed Web of Science ®Google Scholar
• Bonilla-Jaime, H., Sánchez-Salcedo, J. A., Estevez-Cabrera, M. M., Molina-Jiménez, T., Cortes-Altamirano, J. L., & Alfaro-Rodríguez, A. (2022). Depression and pain: Use of antidepressants. Current Neuropharmacology, 20(2), 384–402. doi: 10.2174/1570159X19666210609161447.
   PubMed Web of Science ®Google Scholar
• Bornemann, J., Close, J. B., Spriggs, M. J., Carhart-Harris, R., & Roseman, L. (2021). Self-medication for chronic pain using classic psychedelics: A qualitative investigation to inform future research. Frontiers in Psychiatry, 12, 735427. doi: 10.3389/fpsyt.2021.735427.
   PubMed Web of Science ®Google Scholar
• Boswel, G., Bekersky, I., Mekki, Q., & Eisenach, J. (1997). Plasma concentrations and disposition of clonidine following a constant 14-day epidural infusion in cancer patients. Clinical Therapeutics, 19(5), 1024–1030. doi: 10.1016/s0149-2918(97)80054-9.
   PubMed Web of Science ®Google Scholar
• Branton, M. W., Hopkins, T. J., & Nemec, E. C. (2021). Duloxetine for the reduction of opioid use in elective orthopedic surgery: A systematic review and meta-analysis. International Journal of Clinical Pharmacy, 43(2), 394–403. doi: 10.1007/s11096-020-01216-9.
   PubMed Web of Science ®Google Scholar
• Bredlau, A. L., Thakur, R., Korones, D. N., & Dworkin, R. H. (2013). Ketamine for pain in adults and children with cancer: A systematic review and synthesis of the literature. Pain Medicine, 14(10), 1505–1517. doi: 10.1111/pme.12182.
   PubMed Web of Science ®Google Scholar
• Brown, T. K., & Alper, K. (2018). Treatment of opioid use disorder with ibogaine: Detoxification and drug use outcomes. The American Journal of Drug and Alcohol Abuse, 44(1), 24–36. doi: 10.1080/00952990.2017.1320802.
   PubMed Web of Science ®Google Scholar
• Caraci, F., Merlo, S., Drago, F., Caruso, G., Parenti, C., & Sortino, M. A. (2019). Rescue of noradrenergic system as a novel pharmacological strategy in the treatment of chronic pain: Focus on microglia activation. Frontiers in Pharmacology, 10, 1024. doi: 10.3389/fphar.2019.01024.
   PubMed Web of Science ®Google Scholar
• Carroll, K. M., DeVito, E. E., Yip, S. W., Nich, C., & Sofuoglu, M. (2019). Double-blind placebo-controlled trial of galantamine for methadone-maintained individuals with cocaine use disorder: Secondary analysis of effects on illicit opioid use. The American Journal on Addictions, 28(4), 238–245. doi: 10.1111/ajad.12904.
   PubMed Web of Science ®Google Scholar
• Castellanos, J. P., Woolley, C., Bruno, K. A., Zeidan, F., Halberstadt, A., & Furnish, T. (2020). Chronic pain and psychedelics: A review and proposed mechanism of action. Regional Anesthesia and Pain Medicine, 45(7), 486–494. doi: 10.1136/rapm-2020-101273.
   PubMed Web of Science ®Google Scholar
• Chen, T., & Zhao, M. (2019). Meeting the challenges of opioid dependence in China: Experience of opioid agonist treatment. Current Opinion in Psychiatry, 32(4), 282–287. doi: 10.1097/YCO.0000000000000509.
   PubMed Web of Science ®Google Scholar
• Cheung, K. W. A., Chan, P. C., & Lo, S. H. (2020). The use of ketamine in the management of refractory cancer pain in a palliative care unit. Annals of Palliative Medicine, 9(6), 4478–4489. doi: 10.21037/apm.2019.09.09.
   PubMed Web of Science ®Google Scholar
• Chou, R., Turner, J. A., Devine, E. B., Hansen, R. N., Sullivan, S. D., Blazina, I., Dana, T., Bougatsos, C., & Deyo, R. A. (2015). The effectiveness and risks of long-term opioid therapy for chronic pain: A systematic review for a National Institutes of Health Pathways to Prevention Workshop. Annals of Internal Medicine, 162(4), 276–286. doi: 10.7326/M14-2559.
   PubMed Web of Science ®Google Scholar
• Cobb, J., Craig, W., Richard, J., Snow, E., Turcotte, H., Warters, R., & Quaye, A. (2021). Low-dose ketamine infusion for post-cesarean delivery analgesia in patients with opioid use disorder. International Journal of Obstetric Anesthesia, 47, 103170. doi: 10.1016/j.ijoa.2021.103170.
   PubMed Web of Science ®Google Scholar
• Compton, P. A., Ling, W., & Torrington, M. A. (2008). Lack of effect of chronic dextromethorphan on experimental pain tolerance in methadone-maintained patients. Addiction Biology, 13(3-4), 393–402. doi: 10.1111/j.1369-1600.2008.00112.x.
   PubMed Web of Science ®Google Scholar
• Compton, P., Kehoe, P., Sinha, K., Torrington, M. A., & Ling, W. (2010). Gabapentin improves cold-pressor pain responses in methadone-maintained patients. Drug and Alcohol Dependence, 109(1–3), 213–219. doi: 10.1016/j.drugalcdep.2010.01.006.
   PubMed Web of Science ®Google Scholar
• Cook, M. I., Kushelev, M., Coffman, J. H., & Coffman, J. C. (2022). Analgesic outcomes in opioid use disorder ­patients receiving spinal anesthesia with or without intrathecal clonidine for cesarean delivery: A retrospective investigation. Journal of Pain Research, 15, 1191–1201. doi: 10.2147/JPR.S358045.
   PubMed Web of Science ®Google Scholar
• Cooper, Z. D., Bedi, G., Ramesh, D., Balter, R., Comer, S. D., & Haney, M. (2018). Impact of co-administration of oxycodone and smoked cannabis on analgesia and abuse liability. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology, 43(10), 2046–2055. doi: 10.1038/s41386-018-0011-2.
   PubMed Web of Science ®Google Scholar
• Cooper, Z. D., Johnson, K. W., Vosburg, S. K., Sullivan, M. A., Manubay, J., Martinez, D., Jones, J. D., Saccone, P. A., & Comer, S. D. (2017). Effects of ibudilast on oxycodone-induced analgesia and subjective effects in opioid-dependent volunteers. Drug and Alcohol Dependence, 178, 340–347. doi: 10.1016/j.drugalcdep.2017.04.029.
   PubMed Web of Science ®Google Scholar
• Cooper, Z. D., Jones, J. D., & Comer, S. D. (2012). Glial modulators: A novel pharmacological approach to altering the behavioral effects of abused substances. Expert Opinion on Investigational Drugs, 21(2), 169–178. doi: 10.1517/13543784.2012.651123.
   PubMed Web of Science ®Google Scholar
• Culp, C., Kim, H. K., & Abdi, S. (2020). Ketamine use for cancer and chronic pain management. Frontiers in Pharmacology, 11, 599721. doi: 10.3389/fphar.2020.599721.
   PubMed Web of Science ®Google Scholar
• Davis, A. K., Barrett, F. S., & Griffiths, R. R. (2020). Psychological flexibility mediates the relations between acute psychedelic effects and subjective decreases in depression and anxiety. Journal of Contextual Behavioral Science, 15, 39–45. doi: 10.1016/j.jcbs.2019.11.004.
   PubMed Web of Science ®Google Scholar
• Davis, A. K., Barsuglia, J. P., Windham-Herman, A. M., Lynch, M., & Polanco, M. (2017). Subjective effectiveness of ibogaine treatment for problematic opioid consumption: Short- and long-term outcomes and current psychological functioning. Journal of Psychedelic Studies, 1(2), 65–73. doi: 10.1556/2054.01.2017.009.
   PubMedGoogle Scholar
• Davis, A. K., Renn, E., Windham-Herman, A. M., Polanco, M., & Barsuglia, J. P. (2018). A mixed-method analysis of persisting effects associated with positive outcomes following ibogaine detoxification. Journal of Psychoactive Drugs, 50(4), 287–297. doi: 10.1080/02791072.2018.1487607.
   PubMed Web of Science ®Google Scholar
• De Aquino JP. Cannabidiol in Opioid Use Disorder and Chronic Pain. ClinicalTrials.gov identifier: NCT04587791. Updated March 27, 2022. Accessed June 23, 2023. https://ClinicalTrials.gov/show/NCT04587791
   Google Scholar
• De Aquino JP. Effects of Dronabinol in Opioid Maintained Patients. ClinicalTrials.gov identifier: NCT04025359. Updated March 26, 2023. Accessed June 23, 2023. https://ClinicalTrials.gov/show/NCT04025359
   Google Scholar
• De Aquino JP. Safety and Tolerability of Cannabidiol Among Persons with Opioid Use Disorder Receiving Methadone or Buprenorphine. ClinicalTrials.gov identifier: NCT05076370. Updated October 13, 2021. Accessed June 23, 2023. https://ClinicalTrials.gov/show/NCT05076370
   Google Scholar
• De Aquino, J. P., Parida, S., Avila-Quintero, V. J., Flores, J., Compton, P., Hickey, T., Gómez, O., & Sofuoglu, M. (2021). Opioid-induced analgesia among persons with opioid use disorder receiving methadone or buprenorphine: A systematic review of experimental pain studies. Drug and Alcohol Dependence, 228, 109097. doi: 10.1016/j.drugalcdep.2021.109097.
   PubMed Web of Science ®Google Scholar
• de Oliveira Filho, G. R., Kammer, R. S., & Dos Santos, H. C. (2020). Duloxetine for the treatment acute postoperative pain in adult patients: A systematic review with meta-analysis. Journal of Clinical Anesthesia, 63, 109785. doi: 10.1016/j.jclinane.2020.109785.
   PubMed Web of Science ®Google Scholar
• Dieterle, M., Zurbriggen, L., Mauermann, E., Mercer-Chalmers-Bender, K., Frei, P., Ruppen, W., & Schneider, T. (2022). Pain response to cannabidiol in opioid-induced hyperalgesia, acute nociceptive pain, and allodynia using a model mimicking acute pain in healthy adults in a randomized trial (CANAB II). Pain, 163(10), 1919–1928. doi: 10.1097/j.pain.0000000000002591.
   PubMed Web of Science ®Google Scholar
• Drozdz, S. J., Goel, A., McGarr, M. W., Katz, J., Ritvo, P., Mattina, G. F., Bhat, V., Diep, C., & Ladha, K. S. (2022). Ketamine Assisted psychotherapy: A systematic narrative review of the literature. Journal of Pain Research, 15, 1691–1706. doi: 10.2147/JPR.S360733.
   PubMed Web of Science ®Google Scholar
• Dudgeon, D. J., Bruera, E., Gagnon, B., Watanabe, S. M., Allan, S. J., Warr, D. G., MacDonald, S. M., Savage, C., Tu, D., & Pater, J. L. (2007). A phase III randomized, double-blind, placebo-controlled study evaluating dextromethorphan plus slow-release morphine for chronic cancer pain relief in terminally ill patients. Journal of Pain and Symptom Management, 33(4), 365–371. doi: 10.1016/j.jpainsymman.2006.09.017.
   PubMed Web of Science ®Google Scholar
• Dunn, K. E., Bergeria, C. L., Huhn, A. S., Speed, T. J., Mun, C. J., Vandrey, R., & Campbell, C. M. (2021). Within-subject, double-blinded, randomized, and placebo-controlled evaluation of the combined effects of the cannabinoid dronabinol and the opioid hydromorphone in a human laboratory pain model. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology, 46(8), 1451–1459. doi: 10.1038/s41386-021-01007-4.
   PubMed Web of Science ®Google Scholar
• Dunn, K. E., Huhn, A. S., Bergeria, C. L., Gipson, C. D., & Weerts, E. M. (2019). Non-opioid neurotransmitter systems that contribute to the opioid withdrawal syndrome: A review of preclinical and human evidence. The Journal of Pharmacology and Experimental Therapeutics, 371(2), 422–452. doi: 10.1124/jpet.119.258004.
   PubMed Web of Science ®Google Scholar
• Dworkin, R. H., Anderson, B. T., Andrews, N., Edwards, R. R., Grob, C. S., Ross, S., Satterthwaite, T. D., & Strain, E. C. (2022). If the doors of perception were cleansed, would chronic pain be relieved? Evaluating the benefits and risks of psychedelics. The Journal of Pain, 23(10), 1666–1679. doi: 10.1016/j.jpain.2022.05.003.
   PubMed Web of Science ®Google Scholar
• Elman, I., & Borsook, D. (2016). Common brain mechanisms of chronic pain and addiction. Neuron, 89(1), 11–36. doi: 10.1016/j.neuron.2015.11.027.
   PubMed Web of Science ®Google Scholar
• Farsani, D. M., Ghadimi, K., Abrishamkar, R., Montazeri, K., & Peyman, A. (2021). Evaluating sedative effects of dexmedetomidine and morphine in the patients with opioid use disorder undergoing cataract surgery. American Journal of Clinical and Experimental Immunology, 10(1), 30–36.
   PubMed Web of Science ®Google Scholar
• Flanagan, T. W., & Nichols, C. D. (2018). Psychedelics as anti-inflammatory agents. International Review of Psychiatry, 30(4), 363–375. doi: 10.1080/09540261.2018.1481827.
   PubMed Web of Science ®Google Scholar
• Garcia-Romeu, A., Davis, A. K., Erowid, E., Erowid, F., Griffiths, R. R., & Johnson, M. W. (2019). Persisting Reductions in Cannabis, opioid, and stimulant misuse after naturalistic psychedelic use: An online survey. Frontiers in Psychiatry, 10, 955. doi: 10.3389/fpsyt.2019.00955.
   PubMed Web of Science ®Google Scholar
• Gardner, E. A., McGrath, S. A., Dowling, D., & Bai, D. (2022). The opioid crisis: Prevalence and markets of opioids. Forensic Science Review. 34(1), 43–70.
   PubMedGoogle Scholar
• Gilron, I., Bailey, J. M., Tu, D., Holden, R. R., Weaver, D. F., & Houlden, R. L. (2005). Morphine, gabapentin, or their combination for neuropathic pain. The New England Journal of Medicine, 352(13), 1324–1334. doi: 10.1056/NEJMoa042580.
   PubMed Web of Science ®Google Scholar
• Glue, P., Cape, G., Tunnicliff, D., Lockhart, M., Lam, F., Hung, N., Hung, C. T., Harland, S., Devane, J., Crockett, R. S., Howes, J., Darpo, B., Zhou, M., Weis, H., & Friedhoff, L. (2016). Ascending single-dose, double-blind, placebo-controlled safety study of noribogaine in opioid-dependent patients. Clinical Pharmacology in Drug Development, 5(6), 460–468. doi: 10.1002/cpdd.254.
   PubMed Web of Science ®Google Scholar
• Green, J. M., Sundman, M. H., & Chou, Y. H. (2022). Opioid-induced microglia reactivity modulates opioid reward, analgesia, and behavior. Neuroscience and Biobehavioral Reviews, 135, 104544. doi: 10.1016/j.neubiorev.2022.104544.
   PubMed Web of Science ®Google Scholar
• Grof, S., Goodman, L. E., Richards, W. A., & Kurland, A. A. (1973). LSD-assisted psychotherapy in patients with terminal cancer. International Pharmacopsychiatry, 8(3), 129–144. doi: 10.1159/000467984.
   PubMedGoogle Scholar
• Hahn, J., Jo, Y., Yoo, S. H., Shin, J., Yu, Y. M., & Ah, Y. M. (2022). Risk of major adverse events associated with gabapentinoid and opioid combination therapy: A systematic review and meta-analysis. Frontiers in Pharmacology, 13, 1009950. doi: 10.3389/fphar.2022.1009950.
   PubMed Web of Science ®Google Scholar
• Hamill, J., Hallak, J., Dursun, S. M., & Baker, G. (2019). Ayahuasca: Psychological and physiologic effects, pharmacology and potential uses in addiction and mental illness. Current Neuropharmacology, 17(2), 108–128. doi: 10.2174/1570159X16666180125095902.
   PubMed Web of Science ®Google Scholar
• Hardy, J., Quinn, S., Fazekas, B., Plummer, J., Eckermann, S., Agar, M., Spruyt, O., Rowett, D., & Currow, D. C. (2012). Randomized, double-blind, placebo-controlled study to assess the efficacy and toxicity of subcutaneous ketamine in the management of cancer pain. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, 30(29), 3611–3617. doi: 10.1200/JCO.2012.42.1081.
   PubMed Web of Science ®Google Scholar
• Higgins, C., Smith, B. H., & Matthews, K. (2019). Evidence of opioid-induced hyperalgesia in clinical populations after chronic opioid exposure: A systematic review and meta-analysis. British Journal of Anaesthesia, 122(6), e114–e26. doi: 10.1016/j.bja.2018.09.019.
   PubMed Web of Science ®Google Scholar
• Hooten, W. M., & Warner, D. O. (2015). Varenicline for opioid withdrawal in patients with chronic pain: A randomized, single-blinded, placebo controlled pilot trial. Addictive Behaviors, 42, 69–72. doi: 10.1016/j.addbeh.2014.11.007.
   PubMed Web of Science ®Google Scholar
• Hoyt, M. R., Shah, U., Cooley, J., & Temple, M. (2018). Use of epidural clonidine for the management of analgesia in the opioid addicted parturient on buprenorphine maintenance therapy: An observational study. International Journal of Obstetric Anesthesia, 34, 67–72. doi: 10.1016/j.ijoa.2018.01.001.
   PubMed Web of Science ®Google Scholar
• Hser, Y. I., Mooney, L. J., Saxon, A. J., Miotto, K., Bell, D. S., & Huang, D. (2017). Chronic pain among patients with opioid use disorder: Results from electronic health records data. Journal of Substance Abuse Treatment, 77, 26–30. doi: 10.1016/j.jsat.2017.03.006.
   PubMed Web of Science ®Google Scholar
• Hurd, Y. L., Spriggs, S., Alishayev, J., Winkel, G., Gurgov, K., Kudrich, C., Oprescu, A. M., & Salsitz, E. (2019). Cannabidiol for the reduction of cue-induced craving and anxiety in drug-abstinent individuals with heroin use disorder: A double-blind randomized placebo-controlled trial. The American Journal of Psychiatry, 176(11), 911–922. doi: 10.1176/appi.ajp.2019.18101191.
   PubMed Web of Science ®Google Scholar
• IsHak, W. W., Wen, R. Y., Naghdechi, L., Vanle, B., Dang, J., Knosp, M., Dascal, J., Marcia, L., Gohar, Y., Eskander, L., Yadegar, J., Hanna, S., Sadek, A., Aguilar-Hernandez, L., Danovitch, I., & Louy, C. (2018). Pain and depression: A systematic review. Harvard Review of Psychiatry, 26(6), 352–363. doi: 10.1097/HRP.0000000000000198.
   PubMed Web of Science ®Google Scholar
• Jensen, K. P., DeVito, E. E., Yip, S., Carroll, K. M., & Sofuoglu, M. (2018). The cholinergic system as a treatment target for opioid use disorder. Central Nervous System Drugs, 32(11), 981–996. doi: 10.1007/s40263-018-0572-y.
   Google Scholar
• Jiang, S., Xia, R., Yan, L., & Bai, J. (2021). Successful reversal of opioid-induced hyperalgesia and allodynia with duloxetine. Pain Medicine, 22(4), 1010–1012. doi: 10.1093/pm/pnaa184.
   PubMed Web of Science ®Google Scholar
• Jones, J. L., Mateus, C. F., Malcolm, R. J., Brady, K. T., & Back, S. E. (2018). Efficacy of ketamine in the treatment of substance use disorders: A systematic review. Frontiers in Psychiatry, 9, 277. doi: 10.3389/fpsyt.2018.00277.
   PubMed Web of Science ®Google Scholar
• Kane, C. M., Mulvey, M. R., Wright, S., Craigs, C., Wright, J. M., & Bennett, M. I. (2018). Opioids combined with antidepressants or antiepileptic drugs for cancer pain: Systematic review and meta-analysis. Palliative Medicine, 32(1), 276–286. doi: 10.1177/0269216317711826.
   PubMed Web of Science ®Google Scholar
• Kapural, L., Kapural, M., Bensitel, T., & Sessler, D. I. (2010). Opioid-sparing effect of intravenous outpatient ketamine infusions appears short-lived in chronic-pain patients with high opioid requirements. Pain Physician, 13(4), 389–394. doi: 10.36076/ppj.2010/13/389.
   PubMed Web of Science ®Google Scholar
• Karmali, R. N., Bush, C., Raman, S. R., Campbell, C. I., Skinner, A. C., & Roberts, A. W. (2020). Long-term opioid therapy definitions and predictors: A systematic ­review. Pharmacoepidemiology and Drug Safety, 29(3), 252–269. doi: 10.1002/pds.4929.
   PubMed Web of Science ®Google Scholar
• Kast, E. (1966). LSD and the dying patient. The Chicago Medical School Quarterly, 26(2), 80–87.
   PubMedGoogle Scholar
• Kast, E. C., & Collins, V. J. (1964). STUDY OF LYSERGIC ACID DIETHYLAMIDE AS AN ANALGESIC AGENT. Anesthesia and Analgesia, 43, 285–291.
   PubMed Web of Science ®Google Scholar
• Keizer, B. M., Roache, J. D., Jones, J. R., Kalpinski, R. J., Porcerelli, J. H., & Krystal, J. H. (2020). Continuous ketamine infusion for pain as an opportunity for psychotherapy for PTSD: A case series of ketamine-enhanced psychotherapy for PTSD and pain (KEP-P2). Psychotherapy and Psychosomatics, 89(5), 326–329. doi: 10.1159/000507095.
   PubMed Web of Science ®Google Scholar
• Knuijver, T., Schellekens, A., Belgers, M., Donders, R., van Oosteren, T., Kramers, K., & Verkes, R. (2022). Safety of ibogaine administration in detoxification of opioid-dependent individuals: A descriptive open-label observational study. Addiction, 117(1), 118–128. doi: 10.1111/add.15448.
   PubMed Web of Science ®Google Scholar
• Kooijman, N. I., Willegers, T., Reuser, A., Mulleners, W. M., Kramers, C., Vissers, K. C. P., et al. (2023). Are psychedelics the answer to chronic pain: A review of current literature. Pain Pract,
   PubMed Web of Science ®Google Scholar
• Koopmans, J. R., van Doornen, L. J. P., & Boomsma, D. I. (1997). Association between alcohol use and smoking in adolescent and young adult twins: A bivariate genetic analysis. Alcoholism: Clinical & Experimental Research, 21(3), 537–546. doi: 10.1097/00000374-199705000-00022.
   PubMed Web of Science ®Google Scholar
• Krupitsky, E. M., Burakov, A. M., Dunaevsky, I. V., Romanova, T. N., Slavina, T. Y., & Grinenko, A. Y. (2007). Single versus repeated sessions of ketamine-assisted psychotherapy for people with heroin dependence. Journal of Psychoactive Drugs, 39(1), 13–19. doi: 10.1080/02791072.2007.10399860.
   PubMed Web of Science ®Google Scholar
• Krupitsky, E., Burakov, A., Romanova, T., Dunaevsky, I., Strassman, R., & Grinenko, A. (2002). Ketamine psychotherapy for heroin addiction: Immediate effects and two-year follow-up. Journal of Substance Abuse Treatment, 23(4), 273–283. doi: 10.1016/s0740-5472(02)00275-1.
   PubMed Web of Science ®Google Scholar
• Kukkar, A., Bali, A., Singh, N., & Jaggi, A. S. (2013). Implications and mechanism of action of gabapentin in neuropathic pain. Archives of Pharmacal Research, 36(3), 237–251. doi: 10.1007/s12272-013-0057-y.
   PubMed Web of Science ®Google Scholar
• Kuromaru, S., Okada, S., Hanada, M., Kasahara, Y., & Sakamoto, K. (1967). The effect of LSD on the phantom limb phenomenon. J Lancet, 87(1), 22–27.
   PubMedGoogle Scholar
• Latif, Z. H., Skjaervø, I., Solli, K. K., & Tanum, L. (2021). Chronic pain among patients with an opioid use disorder. The American Journal on Addictions, 30(4), 366–375. doi: 10.1111/ajad.13153.
   PubMed Web of Science ®Google Scholar
• Lau, B. K., & Vaughan, C. W. (2014). Descending modulation of pain: the GABA disinhibition hypothesis of analgesia. Current Opinion in Neurobiology, 29, 159–164. doi: 10.1016/j.conb.2014.07.010.
   PubMed Web of Science ®Google Scholar
• Laulin, J. P., Maurette, P., Corcuff, J. B., Rivat, C., Chauvin, M., & Simonnet, G. (2002). The role of ketamine in preventing fentanyl-induced hyperalgesia and subsequent acute morphine tolerance. Anesthesia and Analgesia, 94(5), 1263–1269, table of contents. doi: 10.1097/00000539-200205000-00040.
   PubMed Web of Science ®Google Scholar
• Lauretti, G. R., Gomes, J. M., Reis, M. P., & Pereira, N. L. (1999). Low doses of epidural ketamine or neostigmine, but not midazolam, improve morphine analgesia in epidural terminal cancer pain therapy. Journal of Clinical Anesthesia, 11(8), 663–668. doi: 10.1016/s0952-8180(99)00122-1.
   PubMed Web of Science ®Google Scholar
• Lauretti, G. R., Lima, I. C., Reis, M. P., Prado, W. A., & Pereira, N. L. (1999). Oral ketamine and transdermal nitroglycerin as analgesic adjuvants to oral morphine therapy for cancer pain management. Anesthesiology, 90(6), 1528–1533. doi: 10.1097/00000542-199906000-00005.
   PubMed Web of Science ®Google Scholar
• LaVigne, J. E., & Alles, S. R. A. (2022). CCK2 receptors in chronic pain. Neurobiology of Pain), 11, 100092. doi: 10.1016/j.ynpai.2022.100092.
   PubMedGoogle Scholar
• Leal, P. C., Salomão, R., Brunialti, M. K., & Sakata, R. K. (2015). Evaluation of the effect of ketamine on remifentanil-induced hyperalgesia: A double-blind, randomized study. Journal of Clinical Anesthesia, 27(4), 331–337. doi: 10.1016/j.jclinane.2015.02.002.
   PubMed Web of Science ®Google Scholar
• Lee, M., Silverman, S. M., Hansen, H., Patel, V. B., & Manchikanti, L. (2011). A comprehensive review of opioid-induced hyperalgesia. Pain Physician, 14(2), 145–161. doi: 10.36076/ppj.2011/14/145.
   PubMed Web of Science ®Google Scholar
• Lilius, T. O., Jokinen, V., Neuvonen, M. S., Niemi, M., Kalso, E. A., & Rauhala, P. V. (2015). Ketamine coadministration attenuates morphine tolerance and leads to increased brain concentrations of both drugs in the rat. British Journal of Pharmacology, 172(11), 2799–2813. doi: 10.1111/bph.12974.
   PubMed Web of Science ®Google Scholar
• Liu, H. J., Gao, X. Z., Liu, X. M., Xia, M., Li, W. Y., & Jin, Y. (2014). Effect of intrathecal dexmedetomidine on spinal morphine analgesia in patients with refractory cancer pain. Journal of Palliative Medicine, 17(7), 837–840. doi: 10.1089/jpm.2013.0544.
   PubMed Web of Science ®Google Scholar
• Liu, S., Li, L., Shen, W., Shen, X., Yang, G., & Zhou, W. (2013). Scopolamine detoxification technique for heroin dependence: A randomized trial. Central Nervous System Drugs, 27(12), 1093–1102. doi: 10.1007/s40263-013-0111-9.
   Google Scholar
• Lossignol, D. A., Obiols-Portis, M., & Body, J. J. (2005). Successful use of ketamine for intractable cancer pain. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer, 13(3), 188–193. doi: 10.1007/s00520-004-0684-4.
   PubMed Web of Science ®Google Scholar
• LSD Used As Analgesic. (1964). JAMA, 187(1), A33. doi: 10.1001/jama.1964.03060140099054.
   Google Scholar
• Ludwig, A. M., & Levine, J. (1965). A CONTROLLED COMPARISON OF FIVE BRIEF TREATMENT TECHNIQUES EMPLOYING LSD, HYPNOSIS, AND PSYCHOTHERAPY. American Journal of Psychotherapy, 19, 417–435. doi: 10.1176/appi.psychotherapy.1965.19.3.417.
   PubMed Web of Science ®Google Scholar
• Luginbühl, M., Gerber, A., Schnider, T. W., Petersen-Felix, S., Arendt-Nielsen, L., & Curatolo, M. (2003). Modulation of remifentanil-induced analgesia, hyperalgesia, and tolerance by small-dose ketamine in humans. Anesthesia and Analgesia, 96(3), 726–732. doi: 10.1213/01.ANE.0000048086.58161.18.
   PubMed Web of Science ®Google Scholar
• Malcolm, B. J., Polanco, M., & Barsuglia, J. P. (2018). Changes in withdrawal and craving scores in participants undergoing opioid detoxification utilizing Ibogaine. Journal of Psychoactive Drugs, 50(3), 256–265. doi: 10.1080/02791072.2018.1447175.
   PubMed Web of Science ®Google Scholar
• Mangnus, T. J. P., Dirckx, M., Bharwani, K. D., de Vos, C. C., Frankema, S. P. G., Stronks, D. L., & Huygen, F. J. P. M. (2021). Effect of intravenous low-dose S-ketamine on pain in patients with complex regional pain syndrome: A retrospective cohort study. Pain Practice : The Official Journal of World Institute of Pain, 21(8), 890–897. doi: 10.1111/papr.13056.
   PubMed Web of Science ®Google Scholar
• Marel, C., Sunderland, M., Mills, K. L., Slade, T., Teesson, M., & Chapman, C. (2019). Conditional probabilities of substance use disorders and associated risk factors: Progression from first use to use disorder on alcohol, cannabis, stimulants, sedatives and opioids. Drug and Alcohol Dependence, 194, 136–142. doi: 10.1016/j.drugalcdep.2018.10.010.
   PubMed Web of Science ®Google Scholar
• Mash, D. C., Duque, L., Page, B., & Allen-Ferdinand, K. (2018). Ibogaine detoxification transitions opioid and cocaine abusers between dependence and abstinence: Clinical observations and treatment outcomes. Frontiers in Pharmacology, 9, 529. doi: 10.3389/fphar.2018.00529.
   PubMed Web of Science ®Google Scholar
• Mash, D. C., Kovera, C. A., Pablo, J., Tyndale, R., Ervin, F. R., Kamlet, J. D., & Hearn, W. L. (2001). Ibogaine in the treatment of heroin withdrawal. The Alkaloids. Chemistry and Biology, 56, 155–171. doi: 10.1016/S0099-9598(01)56012-5.
   PubMedGoogle Scholar
• McCarson, K. E., & Enna, S. J. (2014). GABA pharmacology: The search for analgesics. Neurochemical Research, 39(10), 1948–1963. doi: 10.1007/s11064-014-1254-x.
   PubMed Web of Science ®Google Scholar
• McCleane, G. J. (1998). The cholecystokinin antagonist proglumide enhances the analgesic efficacy of morphine in humans with chronic benign pain. Anesthesia & Analgesia, 87(5), 1117–1120. doi: 10.1213/00000539-199811000-00025.
   PubMed Web of Science ®Google Scholar
• McCleane, G. J. (2003). A randomised, double blind, placebo controlled crossover study of the cholecystokinin 2 antagonist L-365,260 as an adjunct to strong opioids in chronic human neuropathic pain. Neuroscience Letters, 338(2), 151–154. doi: 10.1016/s0304-3940(02)01388-5.
   PubMed Web of Science ®Google Scholar
• Mercadante, S., Arcuri, E., & Santoni, A. (2019). Opioid-induced tolerance and hyperalgesia. CNS Drugs, 33(10), 943–955. doi: 10.1007/s40263-019-00660-0.
   PubMed Web of Science ®Google Scholar
• Mercadante, S., Arcuri, E., Tirelli, W., & Casuccio, A. (2000). Analgesic effect of intravenous ketamine in cancer patients on morphine therapy: A randomized, controlled, double-blind, crossover, double-dose study. Journal of Pain and Symptom Management, 20(4), 246–252. doi: 10.1016/s0885-3924(00)00194-9.
   PubMed Web of Science ®Google Scholar
• Metz, V. E., Jones, J. D., Manubay, J., Sullivan, M. A., Mogali, S., Segoshi, A., Madera, G., Johnson, K. W., & Comer, S. D. (2017). Effects of Ibudilast on the subjective, reinforcing, and analgesic effects of oxycodone in recently detoxified adults with opioid dependence. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology, 42(9), 1825–1832. doi: 10.1038/npp.2017.70.
   PubMed Web of Science ®Google Scholar
• Mion, G., & Villevieille, T. (2013). Ketamine pharmacology: An update (pharmacodynamics and molecular aspects, recent findings. CNS Neuroscience & Therapeutics, 19(6), 370–380. doi: 10.1111/cns.12099.
   PubMed Web of Science ®Google Scholar
• Mitchell, J. M., Bergren, L. J., Chen, K. S., & Fields, H. L. (2006). Cholecystokinin is necessary for the expression of morphine conditioned place preference. Pharmacology, Biochemistry, and Behavior, 85(4), 787–795. doi: 10.1016/j.pbb.2006.11.014.
   PubMed Web of Science ®Google Scholar
• Murnion, B. P., Rivas, C., Demirkol, A., Hayes, V., Lintzeris, N., & Nielsen, S. (2020). Acute experimental pain responses in methadone- and buprenorphine/naloxone-maintained patients administered additional opioid or Gabapentin: A double-blind crossover pilot study. Pain Medicine, 21(6), 1188–1198. doi: 10.1093/pm/pnz178.
   PubMed Web of Science ®Google Scholar
• Naef, M., Curatolo, M., Petersen-Felix, S., Arendt-Nielsen, L., Zbinden, A., & Brenneisen, R. (2003). The analgesic effect of oral delta-9-tetrahydrocannabinol (THC), morphine, and a THC-morphine combination in healthy subjects under experimental pain conditions. Pain, 105(1–2), 79–88. doi: 10.1016/s0304-3959(03)00163-5.
   PubMed Web of Science ®Google Scholar
• Narang, S., Gibson, D., Wasan, A. D., Ross, E. L., Michna, E., Nedeljkovic, S. S., & Jamison, R. N. (2008). Efficacy of dronabinol as an adjuvant treatment for chronic pain patients on opioid therapy. The Journal of Pain, 9(3), 254–264. doi: 10.1016/j.jpain.2007.10.018.
   PubMed Web of Science ®Google Scholar
• Nau, F., Jr., Yu, B., Martin, D., & Nichols, C. D. (2013). Serotonin 5-HT2A receptor activation blocks TNF-α mediated inflammation in vivo. PLOS One, 8(10), e75426. doi: 10.1371/journal.pone.0075426.
   PubMed Web of Science ®Google Scholar
• Navratilova, E., Atcherley, C. W., & Porreca, F. (2015). Brain circuits encoding reward from pain relief. Trends in Neurosciences, 38(11), 741–750. doi: 10.1016/j.tins.2015.09.003.
   PubMed Web of Science ®Google Scholar
• Nguyen, J. D., Grant, Y., Creehan, K. M., Hwang, C. S., Vandewater, S. A., Janda, K. D., Cole, M., & Taffe, M. A. (2019). Δ(9)-tetrahydrocannabinol attenuates oxycodone self-administration under extended access conditions. Neuropharmacology, 151, 127–135. doi: 10.1016/j.neuropharm.2019.04.010.
   PubMed Web of Science ®Google Scholar
• Nielsen, S., Sabioni, P., Trigo, J. M., Ware, M. A., Betz-Stablein, B. D., Murnion, B., Lintzeris, N., Khor, K. E., Farrell, M., Smith, A., & Le Foll, B. (2017). Opioid-sparing effect of cannabinoids: A systematic review and meta-analysis. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology, 42(9), 1752–1765. doi: 10.1038/npp.2017.51.
   PubMed Web of Science ®Google Scholar
• Noller, G. E., Frampton, C. M., & Yazar-Klosinski, B. (2018). Ibogaine treatment outcomes for opioid dependence from a twelve-month follow-up observational study. The American Journal of Drug and Alcohol Abuse, 44(1), 37–46. doi: 10.1080/00952990.2017.1310218.
   PubMed Web of Science ®Google Scholar
• Ocker, A. C., Shah, N. B., Schwenk, E. S., Witkowski, T. A., Cohen, M. J., & Viscusi, E. R. (2020). Ketamine and cognitive behavioral therapy for rapid opioid tapering with sustained opioid abstinence: A case report and 1-year follow-up. Pain Practice : The Official Journal of World Institute of Pain, 20(1), 95–100. doi: 10.1111/papr.12829.
   PubMed Web of Science ®Google Scholar
• Pahnke, W. N., Kurland, A. A., Goodman, L. E., & Richards, W. A. (1969). LSD-assisted psychotherapy with terminal cancer patients. Current Psychiatric Therapies, 9, 144–152.
   PubMedGoogle Scholar
• Pauly, V., Pradel, V., Pourcel, L., Nordmann, S., Frauger, E., Lapeyre-Mestre, M., Micallef, J., & Thirion, X. (2012). Estimated magnitude of diversion and abuse of opioids relative to benzodiazepines in France. Drug and Alcohol Dependence, 126(1-2), 13–20. doi: 10.1016/j.drugalcdep.2012.03.009.
   PubMed Web of Science ®Google Scholar
• Peek, A. L., Rebbeck, T., Puts, N. A., Watson, J., Aguila, M. R., & Leaver, A. M. (2020). Brain GABA and glutamate levels across pain conditions: A systematic literature review and meta-analysis of 1H-MRS studies using the MRS-Q quality assessment tool. NeuroImage, 210, 116532. doi: 10.1016/j.neuroimage.2020.116532.
   PubMed Web of Science ®Google Scholar
• Phillips, W. J., Gadiraju, S., Dickey, S., Galli, R., & Lerant, A. A. (2007). Dexmedetomidine relieves pain associated with acute sickle cell crisis. Journal of Pain and Symptom Management, 34(4), 346–349. doi: 10.1016/j.jpainsymman.2007.07.001.
   PubMed Web of Science ®Google Scholar
• Pisano, V. D., Putnam, N. P., Kramer, H. M., Franciotti, K. J., Halpern, J. H., & Holden, S. C. (2017). The association of psychedelic use and opioid use disorders among illicit users in the United States. Journal of Psychopharmacology , 31(5), 606–613. doi: 10.1177/0269881117691453.
   PubMed Web of Science ®Google Scholar
• Procházka, J. (2008). Our experiences with analgesic effect of intrathecal administration of midazolam. Bolest, 11(1), 36–45.
   Google Scholar
• Ramaekers, J. G., Hutten, N., Mason, N. L., Dolder, P., Theunissen, E. L., Holze, F., Liechti, M. E., Feilding, A., & Kuypers, K. P. (2021). A low dose of lysergic acid diethylamide decreases pain perception in healthy volunteers. Journal of Psychopharmacology, 35(4), 398–405. doi: 10.1177/0269881120940937.
   PubMed Web of Science ®Google Scholar
• Rigo, F. K., Trevisan, G., Godoy, M. C., Rossato, M. F., Dalmolin, G. D., & Silva, M. A. (2017). Management of neuropathic chronic pain with methadone combined with ketamine: A randomized, double blind, active-controlled clinical trial. Pain Physician, 20(3), 207–215.
   PubMed Web of Science ®Google Scholar
• Roberts, J. D., Gennings, C., & Shih, M. (2006). Synergistic affective analgesic interaction between delta-9-tetrahydrocannabinol and morphine. European Journal of Pharmacology, 530(1-2), 54–58. doi: 10.1016/j.ejphar.2005.11.036.
   PubMed Web of Science ®Google Scholar
• Rodríguez, L., López, A., Moyna, G., Seoane, G. A., Davyt, D., Vázquez, Á., Hernández, G., & Carrera, I. (2022). New Insights into the chemical composition of Ayahuasca. ACS Omega, 7(14), 12307–12317. doi: 10.1021/acsomega.2c00795.
   PubMed Web of Science ®Google Scholar
• Sanders, J. C., Gerstein, N., Torgeson, E., & Abram, S. (2009). Intrathecal baclofen for postoperative analgesia after total knee arthroplasty. Journal of Clinical Anesthesia, 21(7), 486–492. doi: 10.1016/j.jclinane.2008.12.019.
   PubMed Web of Science ®Google Scholar
• Savage, C., & McCabe, O. L. (1973). Residential psychedelic (LSD) therapy for the narcotic addict. A controlled study. Archives of General Psychiatry, 28(6), 808–814. doi: 10.1001/archpsyc.1973.01750360040005.
   PubMed Web of Science ®Google Scholar
• Schliessbach, J., Vuilleumier, P. H., Siegenthaler, A., Bütikofer, L., Limacher, A., Juni, P., Zeilhofer, H. U., Arendt-Nielsen, L., & Curatolo, M. (2017). Analgesic effect of clobazam in chronic low-back pain but not in experimentally induced pain. European Journal of Pain , 21(8), 1336–1345. doi: 10.1002/ejp.1032.
   PubMed Web of Science ®Google Scholar
• Schneider, T., Zurbriggen, L., Dieterle, M., Mauermann, E., Frei, P., Mercer-Chalmers-Bender, K., & Ruppen, W. (2022). Pain response to cannabidiol in induced acute nociceptive pain, allodynia, and hyperalgesia by using a model mimicking acute pain in healthy adults in a randomized trial (CANAB I). Pain, 163(1), e62–e71. doi: 10.1097/j.pain.0000000000002310.
   PubMed Web of Science ®Google Scholar
• Schwenk, E. S., Viscusi, E. R., Buvanendran, A., Hurley, R. W., Wasan, A. D., Narouze, S., Bhatia, A., Davis, F. N., Hooten, W. M., & Cohen, S. P. (2018). Consensus guidelines on the use of intravenous Ketamine Infusions for acute pain management from the American society of regional anesthesia and pain medicine, the American academy of pain medicine, and the American society of anesthesiologists. Regional Anesthesia and Pain Medicine, 43(5), 456–466. doi: 10.1097/AAP.0000000000000806.
   PubMed Web of Science ®Google Scholar
• Sebret, A., Léna, I., Crété, D., Matsui, T., Roques, B. P., & Daugé, V. (1999). Rat Hippocampal neurons are critically involved in physiological improvement of memory processes induced by cholecystokinin-b receptor stimulation. The Journal of Neuroscience : The Official Journal of the Society for Neuroscience, 19(16), 7230–7237. doi: 10.1523/JNEUROSCI.19-16-07230.1999.
   PubMed Web of Science ®Google Scholar
• Serrao, J. M., Marks, R. L., Morley, S. J., & Goodchild, C. S. (1992). Intrathecal midazolam for the treatment of chronic mechanical low back pain: A controlled comparison with epidural steroid in a pilot study. Pain, 48(1), 5–12. doi: 10.1016/0304-3959(92)90125-U.
   PubMed Web of Science ®Google Scholar
• Sheehy, K. A., Finkel, J. C., Darbari, D. S., Guerrera, M. F., & Quezado, Z. M. (2015). Dexmedetomidine as an adjuvant to analgesic strategy during vaso-occlusive episodes in adolescents with sickle-cell disease. Pain Practice : The Official Journal of World Institute of Pain, 15(8), E90–7. doi: 10.1111/papr.12336.
   PubMed Web of Science ®Google Scholar
• Slatkin, N. E., Rhiner, M., & Bolton, T. M. (2001). Donepezil in the treatment of opioid-induced sedation: Report of six cases. Journal of Pain and Symptom Management, 21(5), 425–438. doi: 10.1016/s0885-3924(01)00270-6.
   PubMed Web of Science ®Google Scholar
• Smallwood, R. F., Price, L. R., Campbell, J. L., Garrett, A. S., Atalla, S. W., Monroe, T. B., Aytur, S. A., Potter, J. S., & Robin, D. A. (2019). Network alterations in comorbid chronic pain and opioid addiction: An exploratory approach. Frontiers in Human Neuroscience, 13, 174. doi: 10.3389/fnhum.2019.00174.
   PubMed Web of Science ®Google Scholar
• Srivastava, A. B., Mariani, J. J., & Levin, F. R. (2020). New directions in the treatment of opioid withdrawal. Lancet, 395(10241), 1938–1948. doi: 10.1016/S0140-6736(20)30852-7.
   PubMed Web of Science ®Google Scholar
• Staud, R., Vierck, C. J., Robinson, M. E., & Price, D. D. (2005). Effects of the N-methyl-D-aspartate receptor ­antagonist dextromethorphan on temporal summation of pain are similar in fibromyalgia patients and normal control subjects. The Journal of Pain, 6(5), 323–332. doi: 10.1016/j.jpain.2005.01.357.
   PubMed Web of Science ®Google Scholar
• Stoicea, N., Russell, D., Weidner, G., Durda, M., Joseph, N. C., Yu, J., & Bergese, S. D. (2015). Opioid-induced hyperalgesia in chronic pain patients and the mitigating effects of gabapentin. Frontiers in Pharmacology, 6, 104. doi: 10.3389/fphar.2015.00104.
   PubMed Web of Science ®Google Scholar
• Subramaniam, K., Akhouri, V., Glazer, P. A., Rachlin, J., Kunze, L., Cronin, M., Desilva, D., Asdourian, C. P., & Steinbrook, R. A. (2011). Intra- and postoperative very low dose intravenous ketamine infusion does not increase pain relief after major spine surgery in patients with preoperative narcotic analgesic intake. Pain Medicine, 12(8), 1276–1283. doi: 10.1111/j.1526-4637.2011.01144.x.
   PubMed Web of Science ®Google Scholar
• Teixeira, P. J., Johnson, M. W., Timmermann, C., Watts, R., Erritzoe, D., Douglass, H., Kettner, H., & Carhart-Harris, R. L. (2022). Psychedelics and health behaviour change. Journal of Psychopharmacology , 36(1), 12–19. doi: 10.1177/02698811211008554.
   PubMed Web of Science ®Google Scholar
• Thomas, G., Lucas, P., Capler, N. R., Tupper, K. W., & Martin, G. (2013). Ayahuasca-assisted therapy for addiction: Results from a preliminary observational study in Canada. Current Drug Abuse Reviews, 6(1), 30–42. doi: 10.2174/15733998113099990003.
   PubMedGoogle Scholar
• Trujillo, K. A., & Akil, H. (1991). Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801. Science , 251(4989), 85–87. doi: 10.1126/science.1824728.
   PubMed Web of Science ®Google Scholar
• Tsui, J. I., Herman, D. S., Kettavong, M., Anderson, B. J., & Stein, M. D. (2011). Escitalopram is associated with reductions in pain severity and pain interference in opioid dependent patients with depressive symptoms. Pain, 152(11), 2640–2644. doi: 10.1016/j.pain.2011.08.011.
   PubMed Web of Science ®Google Scholar
• Usman, M. A. (2022). Opioid crisis: The African perspective. Disaster Medicine and Public Health Preparedness, 16(1), 3–4. doi: 10.1017/dmp.2020.259.
   PubMed Web of Science ®Google Scholar
• Verret, M., Lauzier, F., Zarychanski, R., Perron, C., Savard, X., Pinard, A.-M., Leblanc, G., Cossi, M.-J., Neveu, X., & Turgeon, A. F, (2020). Perioperative use of Gabapentinoids for the management of postoperative acute pain: A systematic review and meta-analysis. Anesthesiology, 133(2), 265–279. doi: 10.1097/ALN.0000000000003428.
   PubMed Web of Science ®Google Scholar
• Vowles, K. E., McEntee, M. L., Julnes, P. S., Frohe, T., Ney, J. P., & van der Goes, D. N. (2015). Rates of opioid misuse, abuse, and addiction in chronic pain: A systematic review and data synthesis. Pain, 156(4), 569–576. doi: 10.1097/01.j.pain.0000460357.01998.f1.
   PubMed Web of Science ®Google Scholar
• Walsh, Z., Mollaahmetoglu, O. M., Rootman, J., Golsof, S., Keeler, J., Marsh, B., Nutt, D. J., & Morgan, C. J. A. (2021). Ketamine for the treatment of mental health and substance use disorders: Comprehensive systematic review. BJPsych Open, 8(1), e19. doi: 10.1192/bjo.2021.1061.
   PubMed Web of Science ®Google Scholar
• Weinbroum, A. A., Gorodetzky, A., Nirkin, A., Kollender, Y., Bickels, J., Marouani, N., Rudick, V., & Meller, I. (2002). Dextromethorphan for the reduction of immediate and late postoperative pain and morphine consumption in orthopedic oncology patients: A randomized, placebo-controlled, double-blind study. Cancer, 95(5), 1164–1170. doi: 10.1002/cncr.10784.
   PubMed Web of Science ®Google Scholar
• Whelan, A., & Johnson, M. I. (2018). Lysergic acid diethylamide and psilocybin for the management of patients with persistent pain: A potential role? Pain Management, 8(3), 217–229. doi: 10.2217/pmt-2017-0068.
   PubMed Web of Science ®Google Scholar
• Yang, C. Y., Wong, C. S., Chang, J. Y., & Ho, S. T. (1996). Intrathecal ketamine reduces morphine requirements in patients with terminal cancer pain. Canadian Journal of Anaesthesia = Journal Canadien D’anesthesie, 43(4), 379–383. doi: 10.1007/BF03011718.
   PubMed Web of Science ®Google Scholar